Top brokers name 3 ASX shares to sell next week

Brokers aren't feeling overly positive on these shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.

Three sell ratings that investors might want to hear about are summarised below. Here's why top brokers think investors ought to sell these shares next week:

Model bear in front of falling line graph, cheap stocks, cheap ASX shares

Image source: Getty Images

Commonwealth Bank of Australia (ASX: CBA)

According to a note out of Goldman Sachs, its analysts have retained their sell rating and cut their price target on this banking giant's shares to $81.74. This follows the release of Commonwealth Bank's first-quarter update, which fell short of Goldman's expectations. The broker notes that while CBA is the preeminent retail banking franchise, its update shows that it is not immune from profitability pressure. In light of this, it doesn't believe its shares deserve to trade at such a premium. The CBA share price ended the week at $97.81.

Mineral Resources Limited (ASX: MIN)

A note out of Morgan Stanley reveals that its analysts have retained their underweight rating and $38.70 price target on this mining and mining services company's shares. The broker remains bearish on Mineral Resources following an annual general meeting update which suggested that its margins could come under pressure due to iron ore price weakness. The Mineral Resources share price was fetching $41.38 at Friday's close.

Xero Limited (ASX: XRO)

Analysts at UBS have retained their sell rating but lifted their price target on this cloud accounting platform provider's shares to $88.00 following its half year results. While UBS was pleased with Xero's performance during the half and expects its growth to accelerate in the second half, it isn't enough for a change of rating. UBS continues to believe Xero's shares are expensive in comparison to peers. The Xero share price ended the week at $151.00.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Xero. The Motley Fool Australia owns shares of and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Buy, hold, sell: Northern Star, Telix, and Virgin Australia shares

Let’s see if they are bullish or bearish on these names.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »

Miner and company person analysing results of a mining company.
Broker Notes

3 reasons to buy BHP shares today

Two leading investment analysts offer their outlook for the BHP share price.

Read more »

Three happy team mates holding the winners trophy.
Broker Notes

What's Bell Potter's updated view on Catapult shares after its earnings results?

This ASX tech stock could be set for growth.

Read more »